E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/7/2017 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley prices $6 million contingent income autocallables on three stocks

By Marisa Wong

Morgantown, W.Va., Feb. 7 – Morgan Stanley Finance LLC priced $6 million of contingent income autocallable securities due Feb. 3, 2020 linked to the worst performing of the common stocks of Amgen Inc., Visa Inc. and NIKE, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by Morgan Stanley.

Each month, the notes will pay a contingent coupon at an annual rate of 9.5% if each stock closes at or above its downside threshold, 60% of its initial level, on the determination date for that month.

The notes will be called at par of $10 plus the contingent coupon if each stock closes above its initial level on any monthly review date beginning May 3.

The payout at maturity will be par plus the final contingent coupon unless any stock finishes below its 60% downside threshold, in which case investors will be fully exposed to any losses of the worst performing stock.

Morgan Stanley & Co. LLC is the agent.

Issuer:Morgan Stanley Finance LLC
Guarantor:Morgan Stanley
Issue:Contingent income autocallable securities
Underlying stocks:Amgen Inc. (Symbol: AMGN), Visa Inc. (Symbol: V) and NIKE, Inc. (Symbol: NKE)
Amount:$6 million
Maturity:Feb. 3, 2020
Coupon:9.5% per year, payable each month that each stock closes at or above downside threshold level on determination date for that month
Price:Par
Payout at maturity:If final share price of least performing stock is greater than or equal to downside threshold level, par plus final contingent coupon; otherwise, full exposure to decline of worst performer
Call:At par plus contingent coupon if each stock closes at or above initial share price on any monthly review date beginning May 3
Initial share prices:$154.43 for Amgen, $83.70 for Visa, $53.08 for Nike
Downside thresholds:$92.658 for Amgen, $50.22 for Visa, $31.848 for Nike; 60% of initial share prices
Pricing date:Jan. 30
Settlement date:Feb. 2
Agent:Morgan Stanley & Co. LLC
Fees:3.5%
Cusip:61768CDX2

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.